Prospective study on Atorvastatin for prevention relapsed acute cerebral infarction in high-risk patient
YU Hai-ya
Abstract
YU Hai-ya
Abstract
Objective:To explore the clinical pharmacological effects of atorvastatin on preventing relapsed cerebral infarction in high-risk patient,and to investigate the influence of atorvastatin on the inflammatory factors,serum lipids and carotid artery atherosclerosis in patients with cerebral infarction.Methods:A total of 156 patients with the first onset of acute cerebral infarction were divided into control group(n=66) and observation group(n=90).The control group was given conventional therapy,observation group take atorvastatin 20 mg/d,both for 6 months.Serum lipids and inflammatory factors,the carotid artery intimal and media thickness(IMT) and plaque areas were measured before and 6 months after treatment.Results:The improvement in serum lipids,carotid artery atherosclerosis,IMT and carotid artery plaque area in observation group were better than those in the control group(P0.05 or 0.01).The six-month recurrence rate of observation group was significantly lower than that of the control group(5.56% vs.21.2%,P0.01).Conclusion:Atorvastatin calcium can significantly improve endothelial function,lipid levels and carotid atherosclerotic plaque stability in patients with acute cerebral infarction,and promote plaque regression,reduced the recurrence rate of cerebral infarction.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To explore the clinical pharmacological effects of atorvastatin on preventing relapsed cerebral infarction in high-risk patient,and to investigate the influence of atorvastatin on the inflammatory factors,serum lipids and carotid artery atherosclerosis in patients with cerebral infarction.Methods:A total of 156 patients with the first onset of acute cerebral infarction were divided into control group(n=66) and observation group(n=90).The control group was given conventional therapy,observation group take atorvastatin 20 mg/d,both for 6 months.Serum lipids and inflammatory factors,the carotid artery intimal and media thickness(IMT) and plaque areas were measured before and 6 months after treatment.Results:The improvement in serum lipids,carotid artery atherosclerosis,IMT and carotid artery plaque area in observation group were better than those in the control group(P0.05 or 0.01).The six-month recurrence rate of observation group was significantly lower than that of the control group(5.56% vs.21.2%,P0.01).Conclusion:Atorvastatin calcium can significantly improve endothelial function,lipid levels and carotid atherosclerotic plaque stability in patients with acute cerebral infarction,and promote plaque regression,reduced the recurrence rate of cerebral infarction.
Key concepts: Medicine, Atorvastatin, Cerebral infarction, Cardiology, Carotid arteries, Internal medicine, Infarction, Blood lipids